Clinical presentations and outcomes of Filipino juvenile systemic lupus erythematosus

Gulay, Carien B.; Dans, Leonila F.
January 2011
Pediatric Rheumatology;2011, Vol. 9 Issue 1, p7
Academic Journal
Objective: Juvenile Systemic Lupus Erythematosus (SLE) varies by location and ethnicity. This study describes the clinical, laboratory profile and outcome of juvenile SLE seen at Philippine General Hospital (PGH) from 2004-2008. Method: Medical charts of all Filipino Juvenile SLE cases admitted at PGH during the 5-year period were reviewed collecting demographic profile, clinical and laboratory manifestations and treatment during disease course. Results: Seventy-eight cases of juvenile SLE were reviewed. There were 7 boys and 71 girls. The mean age at diagnosis was 14 years (SD 2.7) with a range of 8-18 years. Fever (52.5%) and malar rash (41.0%) were the most common features at disease onset. At the time of diagnosis, the most common features were malar rash (65.3%), renal involvement (62.8%) and photosensitivity (55.1%). Mucocutaneous (92.3%), renal (71.7%) and hematologic (69.2%) involvement were the most common features during the entire course of illness. Infection (34.5%) and neurologic (19.0%) complications were observed most frequently. Corticocosteroid treatment was given in most of the patients in the form of prednisone (97.4%) and concomitant methylprednisolone intravenous pulses (29.4%). Nine patients died during the study period. The overall 5-year mortality rate was 11.5%. Infection (77.0%) was the most frequent cause of death. Conclusion: Malar rash was a common feature at disease onset and at diagnosis among Filipinos with juvenile SLE. Throughout the disease course, renal involvement occurs in 71.7% of patients. Infection was the leading cause of complication and death. The clinical presentations of Filipinos with juvenile SLE were similar to juvenile SLE in other countries.


Related Articles

  • Efficacy of mizoribine-tacrolimus-based induction therapy for pediatric lupus nephritis. Tanaka, H; Aizawa, T; Watanabe, S; Oki, E; Tsuruga, K; Imaizumi, T // Lupus;Jul2014, Vol. 23 Issue 8, p813 

    The article examines the efficacy of mizoribine-tacrolimus-based induction therapy for patients with pediatric-onset lupus nephritis (LN). It is said that a favorable outcome in patients with pediatric-onset LN is brought by recent advances in the management of LN. A less toxic treatment is...

  • Chorea as an Initial Manifestation of Systemic Lupus Erythematosus. Arisaka, Osamu; Obinata, Kaoru; Sasaki, Hidekuni; Arisaka, Madoka; Kaneko, Kenichiro // Clinical Pediatrics;May1984, Vol. 23 Issue 5, p298 

    Neurological complications of systemic lupus erythematosus (SLE) are relatively common, but isolated chorea as the initial manifestation of SLE is very rare. We report a 10-year-old girl presenting with chorea, who developed clinical and lab. oratory findings of SLE 10 months after the onset of...

  • Validity and reliability of retrospective assessment of disease activity and flare in observational cohorts of lupus patients. FitzGerald, J D; Grossman, J M // Lupus;1999, Vol. 8 Issue 8, p638 

    Background: The use of validated retrospective tools to assess disease activity in an observational cohort of patients would allow researchers the flexibility to analyze unique exploratory questions. Valid, reliable tools exist for assessing disease activity and flare for Systemic Lupus...

  • Shwartzman phenomenon in a patient with active systemic lupus erythematosus preceding fatal disseminated intravascular coagulation. Riemekasten, G; Ziemer, S; Häupl, T; Melzer, C; Loddenkemper, K; Hauptmann, S; Burmester, GR; Hiepe, F // Lupus;2002, Vol. 11 Issue 4, p204 

    The recurrence of widespread and diverse vascular lesions is a hallmark of systemic lupus erythematosus (SLE). Inflammatory and thrombotic mechanisms almost invariably associated with circulating antiphospholipid antibodies play a role in the pathogenesis of SLE-related vascular disease. Both...

  • Aneurysm of a Saphenous-Vein Bypass Graft. Sutherland, Donald; Block, Peter C. // New England Journal of Medicine;04/12/2001, Vol. 344 Issue 15, p1139 

    The article presents the case study of a 75-year-old man aneurysm of a saphenous-vein bypass graft. The patient was taking 8 mg of prednisone per day for systemic lupus erythematosus. He was admitted to the hospital for the evaluation of an enlarging chest mass. Seventeen years earlier he had...

  • Case 11-2001. Coggins, Cecil H.; McCluskey, Robert T. // New England Journal of Medicine;04/12/2001, Vol. 344 Issue 15, p1152 

    The article presents the case study of a 35-year-old woman with systemic lupus erythematosus. The patient was admitted to the hospital because of rapidly worsening renal failure. Twelve years before admission, she had received a diagnosis of systemic lupus erythematosus, manifested by Raynaud's...

  • Gigantomastia in a patient with systemic lupus erythematosus successfully treated by reduction mammoplasty. Lanzon, A. E.; Navarra, S. V. // Lupus;Dec2009, Vol. 18 Issue 14, p1309 

    The objective of the study was to describe a Filipino woman with systemic lupus erythematosus (SLE) who developed gigantomastia associated with hyperoestrogenemia and successfully treated by reduction mammoplasty. A 37-year-old Filipino woman with SLE of 5-year duration presented with...

  • Therapeutic response and long-term follow-up in a systemic lupus erythematosus patient presenting with Kikuchi's disease. Vil�, L.; Mayor, A.; Silvestrini, I. // Lupus;Feb2001, Vol. 10 Issue 2, p126 

    Kikuchi's disease (KD) can occur in association with systemic lupus erythematosus (SLE). The treatment of concomitant diseases, however, is unclear. We describe a case of a 45-y-old man who presented with generalized histiocytic necrotizing lymphadenitis, fever, malaise and weight loss. Ten...

  • Letter to the Editor. Sabio, J.; Mediavilla, J.; Fernández-Torres, C.; Aliaga, L.; Jiménez-Alonso, J. // Lupus;Jun2001, Vol. 10 Issue 6, p451 

    Provides information on the risk factors related to hypertension in a Spanish systemic lupus erythematosus (SLE) cohort. Risk factors that could contribute to the development of premature vascular events; Association of hypertension with mortality of SLE; Description of the cohort studied;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics